Single B Cell Sorting Platform
Alpha Lifetech’s single B cell sorting platform enables the rapid identification of antigen-specific B cells from various species, including rabbits, mice, camels, sheep, and chickens. By combining single-cell sorting, antibody gene sequencing, and recombinant antibody expression technologies, our platform supports efficient antibody discovery with high specificity and affinity.
Our integrated workflow covers antigen design, immunization, single B cell enrichment, screening, sequencing, expression, purification, and functional validation. This comprehensive approach provides customized antibody discovery solutions to meet diverse research and development needs.
Summary of Single B-Cell Screening Techniques
Single B cell screening technologies can be broadly classified into random isolation and antigen-specific isolation approaches. Random isolation methods separate individual B cells without prior antigen selection and are relatively simple to perform, making them suitable for initial screening or samples with a high frequency of antigen-specific B cells.
In contrast, antigen-specific isolation strategies utilize antigen–antibody recognition to selectively enrich target B cells, making them particularly valuable for identifying rare antigen-specific antibodies, including therapeutic antibodies and antibodies against complex targets. Although these approaches require more advanced workflows, they provide higher specificity and improved efficiency for antibody discovery.
Common single B cell screening approaches include micromanipulation, laser capture microdissection, fluorescence-activated cell sorting (FACS), antigen-labeled sorting, antigen-coated magnetic bead enrichment, microengraving, and immunospot array assays. Each method offers unique advantages and limitations depending on screening objectives, throughput requirements, and downstream applications.
| Category | Approach | Advantages | Limitations |
|---|---|---|---|
|
Random
Isolation
|
Micromanipulation | Simple operation; low equipment requirements | Low efficiency; limited cell types |
| Laser capture microdissection | High positional accuracy; enables visual cell selection | Complex sample preparation; limited automation | |
| Fluorescence-activated cell sorting (FACS) | High accuracy and efficiency; automated; widely applicable | Requires specialized equipment and optimized workflows | |
| Antigen-Specific Isolation | Fluorochrome-labeled antigen sorting | High specificity; high-throughput capability; enables multiparameter analysis | Requires optimized antigen labeling and advanced equipment |
| Antigen-coated magnetic bead enrichment | Simple operation; high reproducibility; effective target B cell enrichment | May influence cell activity and downstream applications | |
| Microengraving | High efficiency and rapid screening capability | Requires specialized equipment; limited scalability | |
| Immunospot array assay | High automation; high accuracy and efficiency | Complex operation; relatively high cost |
single B cell Screening Antibody Service Process
Animal immunzation
B Cell Collection and Enrichment

Single B Cell Sorting
Following isolation, single-cell sequencing technologies are applied to obtain paired heavy chain (VH) and light chain (VL) antibody gene sequences. This high-throughput approach enables rapid antibody discovery and provides valuable sequence information for recombinant antibody production and antibody library construction.

Antibody gene amplification
Antibody expression and purification
Antibody validation
Requirements for immunogen
Quantity: ≥ 2.5 mg
Purity: ≥ 85%
Molecular weight: > 10 kDa
Soluble protein concentration: 0.5–5 mg/mL
Additional protein amount may be required for antigen affinity purification.
Peptide quantity: ≥ 10 mg
Purity: ≥ 90%
Length: ≥ 10 amino acids
Carrier protein conjugation (e.g., KLH, BSA, or OVA) may be required for immunogenicity enhancement. Structural evaluation is recommended for small molecule antigens.
single B cell Sorting Service Workflow
| Steps | Service Content | Timeline |
|---|---|---|
| Step I: Animal Immunization and ELISA Detection | Animals are immunized with selected antigens through optimized immunization protocols. Serum samples are collected and analyzed by ELISA to evaluate antibody titers and immune response. Following successful validation of antibody titers, peripheral blood mononuclear cells (PBMCs) are isolated for single B cell screening. | 10-12 weeks |
| Step II: Single B Cell Sorting | Immune cell samples are collected, and B cells are enriched and prepared for sorting. Antigen-specific B cells are identified using immunostaining markers (e.g., FITC and AF647) and isolated through fluorescence-based single-cell sorting. Positive clones are further analyzed by ELISA and sequencing. | 2-3 weeks |
| Step III: Antibody Sequence Analysis, Expression and Validation | Selected antibody genes are synthesized and expressed using mammalian expression systems. Recombinant antibodies are evaluated by ELISA and other characterization assays to confirm antibody activity. | 3-4 weeks |
| Step IV: Antibody Delivery | Final deliverables include antibody sequences, recombinant antibody products, and experimental reports. Up to 6 antibody sequences are provided, with each expressed antibody delivered at approximately 0.2 mg. | 1 week |


